Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Matson

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Blood|March 9, 2023
Peripheral erythrophagocytosis in paroxysmal cold hemoglobinuriaDaniel R Matson, Eduard Matkovic
Molecular Interventions|May 5, 2011
Spindle poisons and cell fate: a tale of two pathwaysDaniel R Matson, P Todd Stukenberg
Nature Cell Biology|May 31, 2012
Cdt1 throws kinetochore-microtubule attachments for a loopDaniel R Matson, P Todd Stukenberg
The Journal of Cell Biology|May 28, 2014
CENP-I and Aurora B act as a molecular switch that ties RZZ/Mad1 recruitment to kinetochore attachment statusDaniel R Matson, P Todd Stukenberg
Archives of Pathology & Laboratory Medicine|April 9, 2019
Autoimmune Lymphoproliferative Syndrome: An OverviewDaniel R Matson, David T Yang
Reproductive Sciences (Thousand Oaks, Calif.)|October 23, 2024
Immunohistochemical Analysis of GATA2 Expression in Endometrium and its Relationship with Hormone Receptor Expression in Benign and Premalignant Endometrial DisordersAysenur Keske, Usha S Polaki, Daniel R Matson
Case Reports in Pathology|October 12, 2023
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified (DLBCL NOS) Presenting as Multiple Subcutaneous Nodules: An Unusual Cutaneous Presentation of Systemic DiseaseNika Tavberidze, Daniel D Bennett, Daniel R Matson
Pediatric Dermatology|March 5, 2010
Cutaneous alternariosis in an adolescent patientDaniel R Matson, Jennifer D Eudy, Steven C Matson
Experimental and Molecular Pathology|November 25, 2017
AKT activity is elevated in aggressive thyroid neoplasms where it promotes proliferation and invasionDaniel R Matson, Heather Hardin, Darya Buehler, et al.
Journal of Forensic Sciences|August 24, 2017
Fatal Myocarditis Following Treatment with the PD-1 Inhibitor NivolumabDaniel R Matson, Molly A Accola, William M Rehrauer, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Blood|March 9, 2023
Peripheral erythrophagocytosis in paroxysmal cold hemoglobinuriaDaniel R Matson, Eduard Matkovic
Molecular Interventions|May 5, 2011
Spindle poisons and cell fate: a tale of two pathwaysDaniel R Matson, P Todd Stukenberg
Nature Cell Biology|May 31, 2012
Cdt1 throws kinetochore-microtubule attachments for a loopDaniel R Matson, P Todd Stukenberg
The Journal of Cell Biology|May 28, 2014
CENP-I and Aurora B act as a molecular switch that ties RZZ/Mad1 recruitment to kinetochore attachment statusDaniel R Matson, P Todd Stukenberg
Archives of Pathology & Laboratory Medicine|April 9, 2019
Autoimmune Lymphoproliferative Syndrome: An OverviewDaniel R Matson, David T Yang
Reproductive Sciences (Thousand Oaks, Calif.)|October 23, 2024
Immunohistochemical Analysis of GATA2 Expression in Endometrium and its Relationship with Hormone Receptor Expression in Benign and Premalignant Endometrial DisordersAysenur Keske, Usha S Polaki, Daniel R Matson
Case Reports in Pathology|October 12, 2023
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified (DLBCL NOS) Presenting as Multiple Subcutaneous Nodules: An Unusual Cutaneous Presentation of Systemic DiseaseNika Tavberidze, Daniel D Bennett, Daniel R Matson
Pediatric Dermatology|March 5, 2010
Cutaneous alternariosis in an adolescent patientDaniel R Matson, Jennifer D Eudy, Steven C Matson
Experimental and Molecular Pathology|November 25, 2017
AKT activity is elevated in aggressive thyroid neoplasms where it promotes proliferation and invasionDaniel R Matson, Heather Hardin, Darya Buehler, et al.
Journal of Forensic Sciences|August 24, 2017
Fatal Myocarditis Following Treatment with the PD-1 Inhibitor NivolumabDaniel R Matson, Molly A Accola, William M Rehrauer, et al.
Pageof 4